IDENTIFICATION OF CANDIDA SPECIES ISOLATED FROM DIFFERENT CLINICAL SAMPLES AND THEIR SUSCEPTIBILITY AGAINST COMMONLY USED ANTIFUNGAL DRUGS
DOI:
https://doi.org/10.59058/dcrqd453Keywords:
Keywords: Antifungal susceptibility, Candida species, Fluconazole resistanceAbstract
Background & Objectives: Antifungal resistance is becoming prevalent in Candida species globally and
threating the human health. Aim of this study was to identify Candida to species levels isolated from different
clinical samples and analyze their antifungal susceptibility patterns.
Methods: 70 Candida species isolated from 120 different clinical samples were identified and their
antifungal susceptibility testing was carried out against azoles, polyenes, echinocandins and pyrimidine by
using Vitek 2 Compact System.
Results: Candida species were identified in 58.3% of clinical isolates from different samples of patients. The
most frequent strains found in female patients were of C. albicans, followed by C. glabrata, whereas in male
patients C. krusei was the commonest. All of the isolated Candida species showed resistance to Fluconazole
(100%), whereas 46% showed resistance to Itraconazole and 28% were resistant to Voriconazole. However,
the majority of isolates were sensitive to polyenes (Amphotericin B 91%), echinocandins (Caspofungin
84%) and pyrimidine (Flucytosine 80%) respectively.
Conclusion: Identification of Candida species and antifungal susceptibility testing is necessary to help the
physician in deciding on the suitable antifungal drug.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- Non-Commercial — You may not use the material for commercial purposes .
- No-Derivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
